WO2008127283A3 - Engineered metabolic pathways - Google Patents

Engineered metabolic pathways Download PDF

Info

Publication number
WO2008127283A3
WO2008127283A3 PCT/US2007/021473 US2007021473W WO2008127283A3 WO 2008127283 A3 WO2008127283 A3 WO 2008127283A3 US 2007021473 W US2007021473 W US 2007021473W WO 2008127283 A3 WO2008127283 A3 WO 2008127283A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
metabolic pathways
engineered metabolic
invention
certain aspects
engineered
Prior art date
Application number
PCT/US2007/021473
Other languages
French (fr)
Other versions
WO2008127283A2 (en )
Inventor
Joseph M Jacobson
George Church
Brian M Baynes
Original Assignee
Codon Devices Inc
Joseph M Jacobson
George Church
Brian M Baynes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1093General methods of preparing gene libraries, not provided for in other subgroups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes

Abstract

Certain aspects of the present invention provide methods for designing and engineering metabolic pathways. Aspects of the invention also provide metabolic pathway components and cells containing engineered metabolic pathways. Certain aspects of the invention provide medical, pharmaceutical, industrial, agricultural, environmental, and other Nuses for engineered metabolic pathways of the invention.
PCT/US2007/021473 2006-10-06 2007-10-06 Engineered metabolic pathways WO2008127283A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US85001706 true 2006-10-06 2006-10-06
US60/850,017 2006-10-06

Publications (2)

Publication Number Publication Date
WO2008127283A2 true WO2008127283A2 (en) 2008-10-23
WO2008127283A3 true true WO2008127283A3 (en) 2009-02-12

Family

ID=39864499

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/021473 WO2008127283A3 (en) 2006-10-06 2007-10-06 Engineered metabolic pathways

Country Status (1)

Country Link
WO (1) WO2008127283A3 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192976B2 (en) 2008-12-12 2012-06-05 Celexion, Llc Biological synthesis of difunctional alkanes from carbohydrate feedstocks
US8999679B2 (en) 2008-12-18 2015-04-07 Iti Scotland Limited Method for assembly of polynucleic acid sequences
US8404465B2 (en) 2009-03-11 2013-03-26 Celexion, Llc Biological synthesis of 6-aminocaproic acid from carbohydrate feedstocks
GB201010589D0 (en) 2010-06-23 2010-08-11 Iti Scotland Ltd Method and device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032514A (en) * 1988-08-08 1991-07-16 Genentech, Inc. Metabolic pathway engineering to increase production of ascorbic acid intermediates
US20020132308A1 (en) * 2000-08-24 2002-09-19 Mpep @ Page 300-M Novel constructs and their use in metabolic pathway engineering
US20070048793A1 (en) * 2005-07-12 2007-03-01 Baynes Brian M Compositions and methods for biocatalytic engineering
WO2007136835A2 (en) * 2006-05-19 2007-11-29 Codon Devices, Inc Methods and cells for creating functional diversity and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032514A (en) * 1988-08-08 1991-07-16 Genentech, Inc. Metabolic pathway engineering to increase production of ascorbic acid intermediates
US20020132308A1 (en) * 2000-08-24 2002-09-19 Mpep @ Page 300-M Novel constructs and their use in metabolic pathway engineering
US20070048793A1 (en) * 2005-07-12 2007-03-01 Baynes Brian M Compositions and methods for biocatalytic engineering
WO2007136835A2 (en) * 2006-05-19 2007-11-29 Codon Devices, Inc Methods and cells for creating functional diversity and uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHOTANI G, ET AL.: "THE COMMERCIAL PRODUCTION OF CHEMICALS USING PATHWAY ENGINEERING", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1543, 2000, pages 434 - 455, XP004279117 *
ISAACS F J ET AL: "RNA synthetic biology", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 24, no. 5, 5 May 2006 (2006-05-05), pages 545 - 554, XP002456699, ISSN: 1087-0156 *
KLEEREBEZEM M AND HUGENHOLTZ J: "METABOLIC PATHWAY ENGINEERING IN LACTIC ACID BACTERIA", CURRENT OPINION IN BIOTECHNOLOGY, vol. 14, 2003, pages 232 - 237, XP002502471 *
MEYNIAL-SALLES I ET AL: "New tool for metabolic pathway engineering in Escherichia coli: One-step method to modulate expression of chromosomal genes", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 71, no. 4, 1 April 2005 (2005-04-01), pages 2140 - 2144, XP002367550, ISSN: 0099-2240 *

Also Published As

Publication number Publication date Type
WO2008127283A2 (en) 2008-10-23 application

Similar Documents

Publication Publication Date Title
WO2008070268A3 (en) Pharmaceutical compositions
WO2008087774A1 (en) Antioxidant
WO2007127834A3 (en) Compositions and methods of preparation thereof
WO2006124713A3 (en) 4-biarylyl-1-phenylazetidin-2-ones
WO2010099231A3 (en) Automated systems for manufacturing patient-specific orthopedic implants and instrumentation
WO2007100535A3 (en) Oxyntomodulin derivatives
WO2005118008A3 (en) Compositions and articles containing a crosslinked polymer matrix and an immobilized active liquid, as well as methods of making and using the same
WO2008002472A3 (en) Systematic evaluation of sequence and activity relationships using site evaluation libraries for engineering multiple properties
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
Srivastava Anarakshit evam aarakshit chhatron ki buddhi aankik yogyata smiriti evam adhyayan aadaton ka unki shaikshik uplabdhi se sah sambandh ka tulnatmak adhyayan
GB2459393B (en) Novel capsule formulation for the proton pump inhibitor omeprazole
WO2006086562A3 (en) Phenylazetidinone derivatives
WO2008002674A3 (en) Bicyclic compositions and methods for modulating a kinase cascade
WO2008060795A3 (en) Antimicrobial articles and method of manufacture
WO2009146793A3 (en) Active substance combinations having insecticidal and acaricidal properties
WO2009067636A3 (en) Modified insulin polypeptides and their uses
WO2008078728A1 (en) Ascorbic acid-containing pharmaceutical composition
GB0618496D0 (en) Blood typing
GB0619677D0 (en) Destruction of chemical substances
GB0618390D0 (en) Spell checker reference list
GB0706099D0 (en) Methods of manufacture and applications of a chelating compound or substances to coat, influence and control nerve ends eliminating the neuro-transmitting
GB2464646B (en) Isolator
GB0617272D0 (en) Pharmaceutical spheroids
GB0605542D0 (en) Pharmaceutical Spheroids
GB0617889D0 (en) Luer connector adaptation

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07873442

Country of ref document: EP

Kind code of ref document: A2